ArticleClinical epigenetics2019

ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.

Madhobi Sen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.